（1）免疫抑制治疗（immunosuppressive therapy IST） 重症再障应在能够提供必要的安全保障，有ATG使用经验的医护人员，包括能够认识和处理ATG的不反应。
基于8个网页-相关网页
Objective: to investigate the correlation between colony stimulating activities of serum from patients with severe aplastic anemia (SAA) and their responses to immunosuppressive therapy (IST).
目的：探讨严重型再生障碍性贫血(SAA)患者血清集落刺激活性与免疫抑制治疗(ist)疗效的关系。
Objective To evaluate the long term outcome of immunosuppressive therapy (IST) in patients with severe aplastic anemia (SAA).
目的评价重型再生障碍性贫血(SAA)患者免疫抑制治疗(ist)后的远期疗效。
应用推荐